Senior Care Pharmacy Coalition (SCPC) Announces New Board Chairman, Executive Leadership Team and Board Members￼
WASHINGTON, July 26, 2022 — Brian Kramer, R.Ph., MBA, President of Forum Extended Care Pharmacy based in Chicago, Ill. will serve as the new Chairman of the Senior Care Pharmacy Coalition (SCPC), the Washington D.C.-based advocacy organization announced today. SCPC is the national organization representing long-term care pharmacy interests in Washington, D.C. Its members operate in all 50 states and serve 850,000 patients daily in skilled nursing and assisted living facilities across the country.
Alongside Mr. Kramer, serving on the new SCPC Executive Committee beginning January 1, 2023 for the 2023-2024 term are:
–Chair-Elect Jill Krueger, President and CEO, Symbria, Inc., based in Warrenville, Ill.
–Treasurer Brian Scott, President, HealthDirect,in E. Syracuse, N.Y.
–Secretary Nathan Skaggs, Chief Operating Officer of Pharmacy Unlimited, San Antonio, Texas
–Immediate Past Chair Robert Warnock, R.Ph., Senior Vice President of Pharmacy Services, Pruitt Health, in Norcross, Ga.
Also serving as new Board Members for the 2023-2025 term are:
–Sam Mahfouz, Managing Member, FusionCare Pharmacy, Alexandria, La.
–David Morton, Chief Operating Officer of Neenah, Wis.I-based Morton’s LTC Pharmacy
–Nathan Skaggs, Chief Operating Officer of Pharmacy Unlimited, San Antonio, Texas
–Doug Smock, CEO, Managing Member, Owner of Infinity Pharmacy Solutions and Infinity Pharmacy in Richardson, Texas
–Jason Wachtl, Vice President of Pharmacy and Clinical Programs and Compliance Officer with Geritom Medical in Minneapolis, Minn.
“LTC pharmacies have an essential role in our health care system, serving one of our nation’s most vulnerable populations in skilled nursing facilities, assisted living facilities, the community and other long-term care settings,” said Mr. Kramer. “With 325 members operating in almost every state nationwide, we seek to continue ensuring lawmakers, regulators and other decision makers understand the distinct, essential role of LTC pharmacies in delivering essential patient care services and improving health outcomes. I’d like to thank Robert Warnock for his effective leadership and service on the Board and look forward to continuing to learn and collaborate with him.”
Alan G. Rosenbloom, President & CEO of SCPC, added “SCPC has and continues to play an integral role in ensuring LTC pharmacies and our patients are recognized in legislation given the complex state of health care today. We are driven to improve payments and reduce administrative burdens for LTC pharmacies and enable them to provide high-quality, affordable care safely across the nation.”
About Senior Care Pharmacy Coalition
The Senior Care Pharmacy Coalition (SCPC) is the only national organization exclusively representing the interests of LTC pharmacies, representing 75% of the sector overall. Its members operate in all 50 states and serve 850,000 patients daily in skilled nursing and assisted living facilities across the country. Visit seniorcarepharmacies.org to learn more.
Senior Care Pharmacy Coalition Provides Comments on Improving Care for Dually Eligible Enrollees
The Senior Care Pharmacy Coalition (SCPC), the only Washington-based organization exclusively representing the interests of long-term care (LTC) pharmacies, has responded to a Request for Information issued by a bipartisan group of Senators led by Senator Bill Cassidy (R-LA) regarding policy recommendations to improve care for enrollees dually eligible for Medicare and Medicaid programs (dual eligibles) and substantially reduce the amount of money both programs otherwise would expect to spend over time.
Let’s improve LTC pharmacy policy in the home
Across all cultures and generations, caregivers have long served an integral role supporting the health of family members’ or friends in need of long-term care (LTC). In many cases, these caregivers are unpaid individuals without formal training — often a spouse, partner, family member, friend or neighbor.
Rosenbloom: Curb PBMs’ power
Despite the purported value of pharmacy benefit managers (PBMs), drug prices remain unaffordable for many Americans (“Prescription drug pricing reform must rein in pharmacy benefit managers,” Web, Oct. 18). As middlemen between the manufacturers, pharmacies and consumers, PBMs are notorious for abusive business practices that impact both patients’ wallets and their access to prescription drugs, while gouging unaffiliated pharmacies.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.